Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05884476 · ClinicalTrials.gov registry record · NA

Randomized Clinical Trial of Re-Evaluating Suicidal Thoughts in Veterans

A NA study of Suicidal Ideation and Suicide, Attempted, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT05884476: Recruiting NA study of Suicidal Ideation and Suicide, Attempted, sponsored by VA Office of Research and Development.

NCT05884476 is a NA study of Suicidal Ideation and Suicide, Attempted that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 180 participants, below the 266-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05884476, a NA study of Suicidal Ideation and Suicide, Attempted, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

Suicide prevention is a top priority for VA as all continue to seek new and inventive ways to reduce suicide rates among Veterans. Many experts agree that suicide prevention efforts could be improved by making suicide-specific interventions easier to access. The current project aims to move toward that goal by testing a web-based suicide prevention intervention using an experimental design. The roughly 40-minute intervention aims to teach Veterans coping skills that are designed to ease the emotional distress that often comes with thoughts of suicide. The project will evaluate whether Veterans who receive this intervention report more improvement in suicidal thoughts and behaviors than Veterans who receive a standard course of health care visits. Suicidal thoughts and behaviors will be measured over the course of one month. The investigators hypothesize that Veterans who receive the intervention will report lower suicidal thoughts and behaviors than those who receive the standard course of health care.

Primary Outcome

Data sourced from Beck Scale for Suicidal Ideation (BSS) self-report measure total score. BSS scores range from 0-38 on 19 items rated on a 0-2 scale. Higher scores indicate greater suicidal ideation severity.

Interventions

  • OTHER Treatment-as-usual
  • BEHAVIORAL Re-Evaluating Suicidal Thoughts

Study Locations (1)

Louisiana

  • Southeast Louisiana Veterans Health Care System, New Orleans, LA - New Orleans

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2024-01-08
Est. Completion 2027-06-30
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT05884476 shows while recruiting

NCT05884476 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 266-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (32% lower).

The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 2 interventions - of which Treatment-as-usual is the first listed.

NCT05884476 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT05884476 about?

NCT05884476 is a clinical study titled "Randomized Clinical Trial of Re-Evaluating Suicidal Thoughts in Veterans". Suicide prevention is a top priority for VA as all continue to seek new and inventive ways to reduce suicide rates among Veterans. Many experts agree that suicide prevention efforts could be improved by making suicide-specific interventions easier to access. The current project aims to move toward t...

What is the current status of trial NCT05884476?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2024-01-08. Estimated completion is 2027-06-30.

What conditions does trial NCT05884476 study?

This clinical trial studies the following conditions: Suicidal Ideation, Suicide, Attempted.

What interventions are being tested in trial NCT05884476?

The interventions under investigation include: Treatment-as-usual (OTHER), Re-Evaluating Suicidal Thoughts (BEHAVIORAL).

Who is sponsoring clinical trial NCT05884476?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05884476 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05884476's enrollment target sits among peer trials

180 32nd of 84 higher than 53 of 84 other Suicidal Ideation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05884476, the US trial registry maintained by the National Library of Medicine. NCT05884476 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.